Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30765781 | 0.84 | F2 (0.33) | — | |
| SCHEMBL30765827 | 0.80 | AKT1 (0.36) | ALDH1A1 | |
| SCHEMBL30765713 | 0.80 | AKT1 (0.36) | ALDH1A1 | |
| SCHEMBL30766059 | 0.76 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL30765616 | 0.74 | LMNA (0.37) | SMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL30765874 | 0.74 | NTRK1 (0.41) | NTRK1ALDH1A1L3MBTL1 | |
| SCHEMBL30765865 | 0.73 | NTRK1 (0.37) | NTRK1SMN1; SMN2 | |
| SCHEMBL30765852 | 0.72 | NTRK1 (0.38) | NTRK1 | |
| SCHEMBL30765657 | 0.71 | F2 (0.36) | NTRK1L3MBTL1 | |
| SCHEMBL30765718 | 0.69 | NTRK1 (0.45) | NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024035686-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |